Task: Answer the multiple choice question.
Question: Which drug exhibits a 18.764\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] NC(=O)C1(N2CCCCC2)CCN(C(=O)CSc2nc3ccccc3s2)CC1
[b] Cc1ccc(N2C(=O)N(CC(=O)Nc3cc(F)ccc3C)C(=O)C2C)cc1
[c] CCc1nnc(NC(=O)CSc2nc(-c3ccccc3)nc3ccccc23)s1
Answer: c. CCc1nnc(NC(=O)CSc2nc(-c3ccccc3)nc3ccccc23)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nnc(NC(=O)CSc2nc(-c3ccccc3)nc3ccccc23)s1
CCc1nnc(NC(=O)CSc2nc(-c3ccccc3)nc3ccccc23)s1
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-(2-phenylquinazolin-4-yl)sulfanylacetamide